Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
HCA Healthcare ( (HCA) ) has provided an announcement.
On June 10, 2025, HCA Inc., a subsidiary of HCA Healthcare, established a commercial paper program to issue up to $4 billion in unsecured notes, guaranteed by HCA Healthcare. The notes, intended for general corporate purposes, will be sold privately in the U.S. commercial paper market and are not registered under the Securities Act of 1933.
The most recent analyst rating on (HCA) stock is a Buy with a $385.00 price target. To see the full list of analyst forecasts on HCA Healthcare stock, see the HCA Stock Forecast page.
Spark’s Take on HCA Stock
According to Spark, TipRanks’ AI Analyst, HCA is a Outperform.
HCA Healthcare’s strong financial performance and positive technical indicators drive a high score. Robust earnings growth and effective cost management highlight operational strength, despite concerns over leverage and valuation constraints.
To see Spark’s full report on HCA stock, click here.
More about HCA Healthcare
HCA Healthcare is a prominent company in the healthcare industry, primarily offering healthcare services and operating hospitals and healthcare facilities. It focuses on providing comprehensive healthcare solutions across various regions.
Average Trading Volume: 1,548,430
Technical Sentiment Signal: Strong Buy
Current Market Cap: $92.46B
For a thorough assessment of HCA stock, go to TipRanks’ Stock Analysis page.